What Is Prescribed for Bronchitis? Medications & Care

Most cases of acute bronchitis are caused by viruses, which means the standard prescription is not an antibiotic but rather a combination of symptom-relief medications and self-care. The typical approach includes over-the-counter pain relievers, cough suppressants or expectorants, adequate fluids, and rest. Despite this, antibiotics remain one of the most overprescribed medications for bronchitis, with studies finding that roughly three out of four acute bronchitis visits result in an unnecessary antibiotic prescription. Understanding what actually works, what doesn’t, and when the situation calls for something stronger can save you a lot of frustration and potentially some side effects.

Why Antibiotics Are Usually Not the Answer

Because acute bronchitis is overwhelmingly viral in origin, antibiotics do not speed recovery for most people who get it. The American College of Physicians and the Centers for Disease Control and Prevention jointly advise that clinicians should not prescribe antibiotics for bronchitis unless pneumonia is suspected.¹ Placebo-controlled trials have consistently shown that antibiotics provide minimal benefit for the condition.²

Yet antibiotics keep getting handed out. A large descriptive study of primary care encounters in the United States found that acute bronchitis had the highest rate of unnecessary antibiotic prescribing among common upper respiratory conditions, with about three-quarters of visits resulting in an unneeded prescription.³ The problem isn’t limited to one country or setting. Research from South Africa found that antibiotics were recommended in roughly 73% of consultations for respiratory infections across both public and private clinics.⁴

Several factors drive this overprescribing. Patients who report symptoms lasting longer or getting worse are more likely to walk out with an antibiotic, as are those with certain exam findings like abnormal lung sounds. Individual clinicians vary dramatically in their prescribing habits, with some being dozens of times more likely to prescribe than others in the same practice.⁵ Urgent care settings and providers with more years in practice also tend to prescribe more frequently.³ If a provider offers you an antibiotic for straightforward bronchitis without signs of pneumonia, it is reasonable to ask whether it is truly needed.

When Antibiotics Do Make Sense

The calculus changes when bronchitis is chronic rather than acute. People with chronic obstructive pulmonary disease (COPD) who experience flare-ups, known as acute exacerbations, can benefit from antibiotics. A Cochrane review found that for outpatients with mild to moderate exacerbations, antibiotics reduced the risk of treatment failure by about 28%. For the sickest patients, those treated in intensive care, the benefit was much larger, cutting treatment failure by roughly 80%.⁶ The distinction matters: if you have underlying COPD or chronic bronchitis and your symptoms suddenly worsen with increased sputum production, a change in sputum color, and more shortness of breath, antibiotics become a legitimate part of the treatment plan.

Pneumonia is the other scenario where antibiotics are clearly warranted. The clinical challenge is that bronchitis and pneumonia can look similar in the early stages. Providers distinguish between them using a combination of fever, lung exam findings like crackles, chest pain, shortness of breath, and heart rate.⁷ A chest X-ray is sometimes ordered when pneumonia is suspected. If you’re told your chest sounds clear and your vitals are normal, that’s a good sign that antibiotics won’t help.

C-Reactive Protein Testing and Smarter Prescribing

One promising approach to cutting unnecessary antibiotic use involves a quick blood test for C-reactive protein, or CRP, a marker that rises when the body is fighting a serious bacterial infection. When doctors use a rapid, in-office CRP test before deciding on antibiotics, prescribing rates drop substantially. A meta-analysis of randomized trials found that CRP point-of-care testing reduced immediate antibiotic prescribing by about 21% compared with usual care.⁸

For COPD exacerbations specifically, a trial published in the New England Journal of Medicine found that CRP-guided prescribing cut antibiotic use from about 77% to 57% without worsening patient outcomes.⁹ In a European primary care trial focused on lower respiratory infections, doctors who used CRP testing prescribed antibiotics to 31% of patients, compared with 53% in the group that didn’t have the test available.¹⁰ This kind of testing is not yet standard everywhere, but it is gaining traction as a way to give both patients and doctors more confidence in the decision to skip antibiotics.

Bronchodilators for Cough

If you’ve had bronchitis and been handed an albuterol inhaler, that’s not unusual. Inhaled bronchodilators like albuterol relax the muscles around your airways, which can ease the persistent cough that makes bronchitis so miserable. One trial found that patients using an albuterol inhaler were significantly less likely to still be coughing after a week compared with those given a placebo inhaler.¹¹ A review in the Annals of Internal Medicine similarly noted that randomized trials support albuterol for reducing cough duration in adults with uncomplicated acute bronchitis.¹²

The benefit is most pronounced for people who have wheezing or signs of airflow limitation during their illness. A Cochrane review of beta2-agonists for acute cough found that the trials showing the clearest improvement were those where a higher proportion of patients were wheezing at baseline.¹³ So if your doctor hears wheezing through a stethoscope, an inhaler is a well-supported choice. If your lungs sound clear and your main complaint is a dry, hacking cough without any tightness, the evidence for bronchodilators is weaker.

Another inhaled option is ipratropium bromide, an anticholinergic that works differently from albuterol. It’s used more often in chronic bronchitis than acute cases. Research in patients with chronic bronchitis and heavy mucus production found that inhaled ipratropium at standard doses improved mucociliary clearance, essentially helping the airways move mucus out more efficiently.¹⁴ If post-infectious bronchial hyperresponsiveness lingers after the infection clears, either albuterol or ipratropium may be considered.¹⁵

Cough Suppressants and What the Evidence Actually Shows

Dextromethorphan, the active ingredient in many over-the-counter cough syrups, is one of the most commonly used medications for bronchitis cough. It works on the brain’s cough center rather than on the airways themselves. For many people it takes the edge off enough to sleep through the night, though the clinical evidence for meaningful cough reduction is modest. It’s generally considered safe at recommended doses.

Benzonatate is a prescription cough suppressant that numbs stretch receptors in the lungs to reduce the cough reflex. It has become increasingly popular in recent years, but its evidence base is surprisingly thin. A systematic review found that the original clinical studies involved very small populations and limited settings, and that its approval rests on evidence that would likely not meet modern regulatory standards.¹⁶ Safety concerns include toxicity from overdose or accidental ingestion, particularly in children. Benzonatate is not dangerous when used properly at prescribed doses, but the gap between its widespread use and the quality of evidence supporting it is worth being aware of.

Oral Steroids Don’t Help Acute Bronchitis

You might expect that a short course of oral steroids, which are routinely used for asthma flares, would tamp down the inflammation causing your bronchitis cough. A well-designed randomized trial tested exactly this by giving adults with acute lower respiratory tract infection either 40 mg of oral prednisolone or a placebo daily for five days. The result was clear: steroids made no meaningful difference. The median duration of moderately bad or worse cough was five days in both groups, and symptom severity scores were nearly identical.¹⁷ The study specifically excluded people with asthma, where steroids do have a clear role. For garden-variety acute bronchitis in someone without asthma, oral steroids add side-effect risk without benefit.

Inhaled corticosteroids occupy a slightly different niche. They are sometimes tried for post-infectious cough that drags on for weeks after the initial infection has resolved, though the evidence supporting their use in that scenario is mixed.¹⁵ If you’ve been coughing for more than three weeks after bronchitis and it’s disrupting your life, a trial of inhaled steroids is a conversation worth having with your doctor, but do not expect the same rapid response you’d see in an asthma exacerbation.

Mucolytics and Expectorants for Chronic Bronchitis

If your bronchitis is the chronic kind, with a productive cough most days for at least three months a year over two consecutive years, mucolytic medications may offer real benefit. These drugs work by thinning mucus so it’s easier to cough up. A Cochrane review of 28 studies covering nearly 7,000 participants found that people taking mucolytics were more likely to stay exacerbation-free compared to those on placebo.¹⁸ An earlier version of the same review estimated that for every seven patients treated with mucolytics for about ten months, one additional patient would remain exacerbation-free who otherwise would not have.¹⁹

The most commonly used mucolytics include N-acetylcysteine and carbocisteine. Guaifenesin, the active ingredient in products like Mucinex, is classified as an expectorant and is widely available over the counter. It is popular and generally harmless, though its evidence base for acute bronchitis specifically is limited. For chronic bronchitis with heavy mucus production, the mucolytic evidence is stronger. Inhaled mucolytic aerosols have also been studied in chronic bronchitis patients, with some showing improvements in lung function measures and reductions in sputum thickness.²⁰

Honey, Fluids, and Other Home Remedies

Non-drug approaches deserve more credit than they typically get for bronchitis care. A cross-sectional study of primary care patients in Switzerland and France found that the most frequently used home remedies for respiratory infections were honey, lemon, thyme, and herbal teas. Among patients who used these remedies, between 77% and 94% considered them effective, depending on the specific remedy.²¹ Patient satisfaction doesn’t prove efficacy, of course, but honey in particular has some research behind it. A review of non-drug remedies for post-viral acute cough found supporting evidence for honey, along with glycerol, saline solutions, and several herbal preparations including thyme, ivy leaf, and elderberry.²²

Staying well-hydrated is one of the simplest and most universally recommended strategies. Warm liquids can soothe an irritated throat, and adequate hydration helps keep mucus from becoming thick and difficult to clear. Using a humidifier or taking steamy showers serves the same purpose. Elevating your head while sleeping can reduce nighttime coughing by preventing mucus from pooling in the back of the throat. None of these remedies will cure bronchitis faster, but they reduce discomfort while your body clears the infection on its own.

Pelargonium Sidoides, the Most-Studied Herbal Option

One herbal extract has accumulated a larger evidence base for acute bronchitis than most pharmaceutical cough products: Pelargonium sidoides, commonly sold as EPs 7630 or under brand names like Umckaloabo. It is a South African geranium extract widely used in Europe. Two early randomized, double-blind, placebo-controlled trials in adults found significant improvements in bronchitis symptom scores after seven days of treatment compared to placebo.²³²⁴ A pediatric trial also found faster symptom improvement in children and adolescents receiving the extract versus placebo, with the biggest gains seen in coughing frequency.

However, a more recent and more rigorous trial from Swiss primary care poured some cold water on these results. This pragmatic, open-label, randomized trial compared EPs 7630 with usual care and found no significant difference between the two groups in the time required to achieve a 50% symptom reduction, with both groups reaching that milestone at a median of four days. Antibiotic use was seven percentage points lower in the herbal extract group, but this difference was not statistically significant. The extract group also reported more adverse events, though all were mild.²⁵ The difference in study design matters here: the earlier positive trials were placebo-controlled and double-blinded, meaning neither patients nor doctors knew who was getting the real treatment. The Swiss trial was open-label, meaning everyone knew which treatment they were receiving, which can dilute placebo effects. On balance, Pelargonium sidoides may offer modest symptomatic relief, but it is not a dramatic game-changer.

What to Do When the Cough Won’t Quit

Acute bronchitis cough typically lasts two to three weeks, but it can drag on well beyond that. When coughing persists for more than three to eight weeks after the initial infection has cleared, it crosses into the territory of post-infectious cough. This happens because the airways remain inflamed and hyperreactive even after the virus is gone, leaving you coughing at triggers that wouldn’t normally bother you: cold air, talking for a long time, exercise, or irritants like perfume.

The management approach for post-infectious cough differs from the acute phase. Inhaled corticosteroids may be tried, though the evidence is mixed. Inhaled bronchodilators like ipratropium or albuterol can help if bronchial hyperresponsiveness is contributing to the persistent cough. For severe, refractory cases where nothing else has worked, a short course of oral corticosteroids may be considered as a last resort.¹⁵ The most important thing to recognize is that post-infectious cough, while annoying, is not dangerous and does not mean the infection is still active. It resolves on its own, though it can take weeks to months.

When Bronchitis Keeps Coming Back

Recurrent or chronic bronchitis often has identifiable triggers beyond just bad luck with viruses. Occupational exposure to dust, gases, vapors, and fumes is a well-documented risk factor. A population-based study found that people exposed to these workplace irritants had a higher risk of chronic bronchitis symptoms like persistent cough and phlegm, and those exposed to gas, vapor, fume combinations or all four categories simultaneously also showed lower lung function.²⁶ Smoking remains the single biggest modifiable risk factor for chronic bronchitis, and quitting is more effective than any medication at slowing the disease’s progression.

Vaccination also plays a preventive role. The annual influenza vaccine reduces the chance of viral infections that trigger bronchitis episodes. For people with COPD or chronic bronchitis, pneumococcal vaccination adds another layer of protection. Evidence suggests that both influenza and pneumococcal vaccinations can help prevent community-acquired pneumonia and acute exacerbations in COPD patients, with pneumococcal vaccination early in the course of the disease helping to maintain stable health.²⁷ If you have chronic bronchitis and haven’t been vaccinated, that’s one of the most impactful steps you can take.